155 related articles for article (PubMed ID: 34123305)
21. Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.
Chen K; Cai H; Zhang H; Zhu H; Gu Z; Gong Q; Luo K
Acta Biomater; 2019 Jan; 84():339-355. PubMed ID: 30503561
[TBL] [Abstract][Full Text] [Related]
22. Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.
Zhang X; Li D; Huang J; Ou K; Yan B; Shi F; Zhang J; Zhang J; Pang J; Kang Y; Wu J
J Mater Chem B; 2019 Jan; 7(2):251-264. PubMed ID: 32254550
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.
Ferreira VFC; Oliveira BL; D'Onofrio A; Farinha CM; Gano L; Paulo A; Bernardes GJL; Mendes F
Bioconjug Chem; 2021 Jan; 32(1):121-132. PubMed ID: 33295756
[TBL] [Abstract][Full Text] [Related]
24. A traceable, GSH/pH dual-responsive nanoparticles with spatiotemporally controlled multiple drugs release ability to enhance antitumor efficacy.
Wang N; Liu C; Yao W; Zhou H; Yu S; Chen H; Qiao W
Colloids Surf B Biointerfaces; 2021 Sep; 205():111866. PubMed ID: 34044333
[TBL] [Abstract][Full Text] [Related]
25. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
26. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy.
Pereira S; Ma G; Na L; Hudoklin S; Kreft ME; Kostevsek N; Al-Jamal WT
Acta Biomater; 2022 Mar; 140():530-546. PubMed ID: 34954416
[TBL] [Abstract][Full Text] [Related]
28. Tetrazine Carbon Nanotubes for Pretargeted In Vivo "Click-to-Release" Bioorthogonal Tumour Imaging.
Li H; Conde J; Guerreiro A; Bernardes GJL
Angew Chem Int Ed Engl; 2020 Sep; 59(37):16023-16032. PubMed ID: 32558207
[TBL] [Abstract][Full Text] [Related]
29. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
[TBL] [Abstract][Full Text] [Related]
30. Synthetic methodology towards allylic
de Geus MAR; Groenewold GJM; Maurits E; Araman C; van Kasteren SI
Chem Sci; 2020 Sep; 11(37):10175-10179. PubMed ID: 34094281
[TBL] [Abstract][Full Text] [Related]
31. Synergy effects of copper ion in doxorubicin-based chelate prodrug for cancer chemo-chemodynamic combination therapy.
Zhang W; Zhang P; Xu X; Li M; Wang S; Mu H; Sun K
Drug Deliv; 2023 Dec; 30(1):2219426. PubMed ID: 37282832
[TBL] [Abstract][Full Text] [Related]
32. Reduction-responsive and bioorthogonal carboxymethyl cellulose based soft hydrogels cross-linked via IEDDA click chemistry for cancer therapy application.
Ali I; Gulfam M; Jo SH; Seo JW; Rizwan A; Park SH; Lim KT
Int J Biol Macromol; 2022 Oct; 219():109-120. PubMed ID: 35931291
[TBL] [Abstract][Full Text] [Related]
33. Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design.
Pereira SGT; Hudoklin S; Kreft ME; Kostevsek N; Stuart MCA; Al-Jamal WT
Mol Pharm; 2019 Apr; 16(4):1573-1585. PubMed ID: 30802065
[TBL] [Abstract][Full Text] [Related]
34. Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.
Meyer JP; Tully KM; Jackson J; Dilling TR; Reiner T; Lewis JS
Bioconjug Chem; 2018 Feb; 29(2):538-545. PubMed ID: 29378403
[TBL] [Abstract][Full Text] [Related]
35. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
Zhou T; Li J; Jia X; Zhao X; Liu P
Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Structurally Diverse
Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
[No Abstract] [Full Text] [Related]
37. Polymer-Doxorubicin Prodrug with Biocompatibility, pH Response, and Main Chain Breakability Prepared by Catalyst-Free Click Reaction.
Li D; Song Y; He J; Zhang M; Ni P
ACS Biomater Sci Eng; 2019 May; 5(5):2307-2315. PubMed ID: 33405781
[TBL] [Abstract][Full Text] [Related]
38. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
39. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
[TBL] [Abstract][Full Text] [Related]
40. Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects.
Yao M; Ma X; Zhang X; Shi L; Liu T; Liang X; Zhao H; Li X; Li L; Gao H; Jia B; Wang F
Theranostics; 2019; 9(3):747-760. PubMed ID: 30809306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
